Growth factor homolog ZVEGF3

Details Growth factor homolog ZVEGF3 Growth factor homolog ZVEGF3

2008-04-22

2011-11-08

Spector, Lorraine (Department: 1647)

Drug, bio-affecting and body treating compositions

Antigen, epitope, or other immunospecific immunoeffector

Hormone or other secreted growth regulatory factor,...

C530S351000, C530S399000

Reexamination Certificate

active

08052976

ABSTRACT:
Polypeptide growth factors, methods of making them, polynucleotides encoding them, antibodies to them, and methods of using them are disclosed. The polypeptides comprise an amino acid segment that is at least 90% identical to residues 46-163 of SEQ ID NO:2 or residues 235-345 of SEQ ID NO:2. Multimers of the polypeptides are also disclosed. The polypeptides, multimeric proteins, and polynucleotides can be used in the study and regulation of cell and tissue development, as components of cell culture media, and as diagnostic agents.

REFERENCES:
patent: 4946778 (1990-08-01), Ladner et al.
patent: 6391311 (2002-05-01), Ferrara et al.
patent: 6455283 (2002-09-01), Ferrara et al.
patent: 6528050 (2003-03-01), Gao et al.
patent: 7691981 (2010-04-01), Gao et al.
patent: 95/14772 (1995-06-01), None
patent: 99/37671 (1999-07-01), None
patent: 99/47677 (1999-09-01), None
patent: 00/04183 (2000-01-01), None
patent: 00/18212 (2000-04-01), None
patent: 00/24774 (2000-05-01), None
patent: 00/32221 (2000-06-01), None
patent: 00/37641 (2000-06-01), None
patent: 00/39284 (2000-07-01), None
patent: 00/53753 (2000-09-01), None
patent: 00/53756 (2000-09-01), None
patent: 00/53758 (2000-09-01), None
patent: 00/53760 (2000-09-01), None
patent: 00/59940 (2000-10-01), None
patent: 00/70050 (2000-11-01), None
The Institute for Genomic Research, EST 40974, Jul. 3, 1997.
The Institute for Genomic Research, EST W21436, Jul. 3, 1997.
Hillier et al., EST 528192, May 9, 1996.
Adams et al., EST 977627, Apr. 21, 1997.
Marra et al., EST 1759738, Jun. 16, 1998.
Marra et al., EST 2236990, Feb. 10, 1999.
National Cancer Institute, Cancer Genome Anatomy Project, EST 2290164, Mar. 3, 1999.
Marra et al., EST 2425258, Apr. 15, 1999.
Ottenwaelder et al., EST 2476351, Apr. 30, 1999.
Duesterhoeft et al., EST 2888195, Jul. 7, 1999.
Ottenwaelder et al., EST 2890217, Jul. 8, 1999.
National Cancer Institute, Cancer Genome Anatomy Project, EST 3182898, Sep. 20, 1999.
Marra et al., EST 3555592, Dec. 3, 1999.
Tsai et al., GenBank Accession No. AF091434, Oct. 1, 1999.
Marra et al., The WashU-HHMI Mouse EST Project, EST 744345, Sep. 23, 1996.
LIFESEQ™ Information Results, Incyte Pharmaceuticals, Inc., INC1302516, May 1999.
LIFESEQ™ Information Results, Incyte Pharmaceuticals, Inc., INC1303909, May 1999.
LIFESEQ™ Information Results, Incyte Pharmaceuticals, Inc., INC2453444, May 1999.
LIFESEQ™ Information Results, Incyte Pharmaceuticals, Inc., INC2451669, May 1999.
LIFESEQ™ Information Results, Incyte Pharmaceuticals, Inc., INC3440025, Jul. 8, 1997.
LIFESEQ™ Information Results, Incyte Pharmaceuticals, Inc., INC2547850, Feb. 4, 1997.
LIFESEQ™ Information Results, Incyte Pharmaceuticals, Inc., INC2962366, Sep. 8, 1997.
LIFESEQ™ Information Results, Incyte Pharmaceuticals, Inc., INC3598059, Sep. 8, 1997.
LIFESEQ™ Information Results, Incyte Pharmaceuticals, Inc., INC3073703, Mar. 12, 1998.
LIFESEQ™ Information Results, Incyte Pharmaceuticals, Inc., INC4825396, Jul. 9, 1998.
LIFESEQ™ Information Results, Incyte Pharmaceuticals, Inc., INC5832763, Feb. 20, 1999.
Li et al., “PDGF-C is a new protease-activated ligand for the PDGF α-receptor,”Nature Cell Biol. 2:302-309, 2000.

Affiliated with

Also associated with

Rating

Growth factor homolog ZVEGF3 does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Growth factor homolog ZVEGF3, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Growth factor homolog ZVEGF3 will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4279197